Online ISSN: 1949-2553
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

CRISPR Clones Shed New Light on Triple-Negative Breast Cancer

Oncotarget | June 9, 2021
Researchers used the CRISPR-Cas9 tool to learn more about the function of the mutant p53 gene in triple-negative breast cancer. continue reading »

Table of Contents: Oncotarget’s Volume 12, Issue #12

Oncotarget | June 8, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 12. continue reading »

Behind the Study: PRAME Associated with Increased Metastatic Risk

Oncotarget | June 7, 2021
Dr. Matthew G. Field discusses his 2016 study published by Oncotarget, entitled, “Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.” continue reading »

Trending With Impact: Novel Urine Protein Biomarkers in Bladder Cancer

Oncotarget | June 3, 2021
Researchers from the University of Houston and UT Southwestern Medical Center conducted a study which aimed to screen urine for potentially useful protein biomarkers of bladder cancer. continue reading »

Can CEA Be Used as a Biomarker for SCCA?

Oncotarget | May 26, 2021
Squamous cell carcinoma of the anal canal (SCCA) most commonly affects women and is closely associated with HPV infection. Researchers search for novel blood-based biomarkers that track responses to SCCA. continue reading »